Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro.
2005
Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
75
Citations
NaN
KQI